KAT2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.6251444634463E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.80806497446429E-14 |
Normal-vs-Stage2 |
7.37430000397055E-08 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
6.341200E-01 |
Stage1-vs-Stage3 |
5.316900E-03 |
Stage1-vs-Stage4 |
1.279710E-03 |
Stage2-vs-Stage3 |
5.907800E-02 |
Stage2-vs-Stage4 |
2.332500E-02 |
Stage3-vs-Stage4 |
5.127200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
3.73034936274053E-14 |
Normal-vs-Asian |
2.562200E-03 |
Caucasian-vs-AfricanAmerican |
3.773600E-01 |
Caucasian-vs-Asian |
8.216200E-01 |
AfricanAmerican-vs-Asian |
5.499200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62658775337832E-12 |
Normal-vs-Female |
3.33066907387547E-16 |
Male-vs-Female |
3.582600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.57225401773576E-12 |
Normal-vs-Age(41-60Yrs) |
1.62481139653892E-12 |
Normal-vs-Age(61-80Yrs) |
3.33066907387547E-16 |
Normal-vs-Age(81-100Yrs) |
4.33399982568972E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.208650E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.135400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.651200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.345400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.850200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.365000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.818600E-04 |
Normal-vs-Grade 2 |
4.66293670342566E-15 |
Normal-vs-Grade 3 |
1.11022302462516E-16 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
2.566200E-01 |
Grade 1-vs-Grade 3 |
8.304500E-03 |
Grade 1-vs-Grade 4 |
2.402500E-04 |
Grade 2-vs-Grade 3 |
1.874450E-02 |
Grade 2-vs-Grade 4 |
3.5805000000444E-06 |
Grade 3-vs-Grade 4 |
1.240010E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62625468647093E-12 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.601820E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
3.43920000034359E-07 |
N0-vs-N1 |
2.345600E-01 |
|
|